<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">diaendo</journal-id><journal-title-group><journal-title xml:lang="ru">Сахарный диабет</journal-title><trans-title-group xml:lang="en"><trans-title>Diabetes mellitus</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0351</issn><issn pub-type="epub">2072-0378</issn><publisher><publisher-name>Endocrinology research centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/DM2014377-82</article-id><article-id custom-type="elpub" pub-id-type="custom">diaendo-6496</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Детская диабетология</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Pediatric diabetology</subject></subj-group></article-categories><title-group><article-title>Функциональное состояние нейтрофильных гранулоцитов и маркеры апоптоза при сахарном диабете 1 типа у детей</article-title><trans-title-group xml:lang="en"><trans-title>Neutrophil granulocyte functional status and expression of apoptosis markers in children with type 1 diabetes</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Барычева</surname><given-names>Людмила Юрьевна</given-names></name><name name-style="western" xml:lang="en"><surname>Barycheva</surname><given-names>Lyudmila Yur'evna</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, профессор кафедры детских инфекционных болезней</p></bio><bio xml:lang="en"><p>MD, PhD, Professor of the Chair of Pediatric Infectious Diseases</p></bio><email xlink:type="simple">for_ludmila@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Эрдни-Горяева</surname><given-names>Наталья Эдуардовна</given-names></name><name name-style="western" xml:lang="en"><surname>Erdni-Goryaeva</surname><given-names>Natalya Eduardovna</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"><p>MD, Endocrinologist of the Stavropol Regional Clinical Diagnostic Center; Competitor of the Chair of Pediatric Infectious Diseases</p></bio><email xlink:type="simple">for_ludmila@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Александрович</surname><given-names>Галина Алексеевна</given-names></name><name name-style="western" xml:lang="en"><surname>Alexandrovich</surname><given-names>Galina Alekseevna</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, доцент, заслуженный врач России, заведующий кафедрой эндокринологии, детской эндокринологии и диабетологии</p></bio><bio xml:lang="en"><p>MD, PhD, Associate Professor, Honored Doctor of Russia, Head of the Chair of Endocrinology, Pediatric Endocrinology, and Diabetology</p></bio><email xlink:type="simple">for_ludmila@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБОУ ВПО Ставропольский государственный медицинский университет, Ставрополь</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Stavropol State Medical University, Stavropol</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>14</day><month>06</month><year>2014</year></pub-date><volume>17</volume><issue>3</issue><fpage>77</fpage><lpage>82</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Барычева Л.Ю., Эрдни-Горяева Н.Э., Александрович Г.А., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Барычева Л.Ю., Эрдни-Горяева Н.Э., Александрович Г.А.</copyright-holder><copyright-holder xml:lang="en">Barycheva L.Y., Erdni-Goryaeva N.E., Alexandrovich G.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.dia-endojournals.ru/jour/article/view/6496">https://www.dia-endojournals.ru/jour/article/view/6496</self-uri><abstract><p>В последние годы доказано, что полиморфноядерные лейкоциты играют важную роль в развитии сахарного диабета (СД). Дисфункция нейтрофилов способствует повреждению ткани поджелудочной железы, а также повышенной восприимчивости к инфекции при СД 1 типа (СД1). Цель.  Изучение функциональной активности нейтрофильных гранулоцитов (НГ) при СД1 у детей. Материалы и методы.  Обследовано 25 детей в возрасте от 7 до 15 лет. Для оценки программируемой клеточной гибели выявляли количество НГ, экспрессирующих маркеры апоптоза (CD95, CD95L, Bcl2). Функциональную активность НГ определяли по показателям фагоцитоза, уровню миелопероксидазы, лизосомальных катионных белков, активных радикалов кислорода. Результаты.  Установлено снижение бактерицидной активности НГ с дефицитом поглощения, секреции активных радикалов кислорода, функционального резерва. Показано увеличение готовности к апоптозу, что сопровождалось повышением экспрессии CD95, снижением ? Bсl2. Выявлено увеличение цитотоксического потенциала нейтрофилов в виде повышения уровня миелопероксидазы и лизосомальных катионных белков. Заключение.  Увеличение апоптотического потенциала НГ на фоне функционально-метаболических изменений может являться отражением их активного вовлечения в иммунопатогенез заболевания. </p></abstract><trans-abstract xml:lang="en"><p>In recent years, polymorphonuclear leukocytes have been proven to play an important role in the development of diabetes mellitus (DM). Neutrophil dysfunction contributes to pancreatic tissue damage as well as an increased susceptibility to infection in type 1 DM (T1DM) patients. Objective.  The objective of this study was to investigate the functional activity of neutrophil granulocytes (NGs) in children with T1DM. Materials and Methods.  This study involved 25 children aged 7?15 years. To evaluate programmed cell death, the number of NGs expressing apoptosis markers (CD95, CD95L and BCL2) was determined. The functional activity of NGs was determined in terms of phagocytosis and the levels of myeloperoxidase, lysosomal cationic proteins and active oxygen radicals. Results.  A reduction in the bactericidal activity of NGs with deficiencies in phagocytosis, secretion of active oxygen radicals and functional reserve was found. An increase in the apoptotic potential of NGs was demonstrated, which was accompanied by an increase in CD95 expression and a decrease in BCL2 expression. An increase in the cytotoxic potential of neutrophils in the form of enhanced levels of myeloperoxidase and lysosomal cationic proteins was revealed. Conclusions.  Therefore, an increase in the apoptotic potential of NGs associated with functional and metabolic changes may reflect the active involvement of NGs in the immunopathogenesis of T1DM. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>сахарный диабет</kwd><kwd>нейтрофилы</kwd><kwd>фагоцитоз</kwd><kwd>миелопероксидаза</kwd><kwd>лизосомальные катионные белки</kwd><kwd>оксидазная активность</kwd><kwd>апоптоз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>diabetes mellitus</kwd><kwd>neutrophils</kwd><kwd>phagocytosis</kwd><kwd>myeloperoxidase</kwd><kwd>lysosomal cationic proteins</kwd><kwd>oxidase activity</kwd><kwd>apoptosis</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена в рамках федеральной целевой научной программы. Номер государственной регистрации 01200954364.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Alba-Loureiro TC, Hirabara SM, Mendonça JR, Curi R, Pithon-Curi TC. Diabetes causes marked changes in function and metabolism of rat neutrophils. Journal of Endocrinology 2006;188(2):295-303. doi: 10.1677/joe.1.06438</mixed-citation><mixed-citation xml:lang="en">Alba-Loureiro TC, Hirabara SM, Mendonça JR, Curi R, Pithon-Curi TC. Diabetes causes marked changes in function and metabolism of rat neutrophils. Journal of Endocrinology 2006;188(2):295-303. doi: 10.1677/joe.1.06438</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Alba-Loureiro TC, Munhoz CD, Martins JO, Cerchiaro GA, Scavone C, Curi R, et al. Neutrophil function and metabolism in individuals with diabetes mellitus. Braz J Med Biol Res 2007;40(8):1037-1044. doi: 10.1590/S0100-879X2006005000143</mixed-citation><mixed-citation xml:lang="en">Alba-Loureiro TC, Munhoz CD, Martins JO, Cerchiaro GA, Scavone C, Curi R, et al. Neutrophil function and metabolism in individuals with diabetes mellitus. Braz J Med Biol Res 2007;40(8):1037-1044. doi: 10.1590/S0100-879X2006005000143</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Valle A, Giamporcaro GM, Scavini M, Stabilini A, Grogan P, Bianconi E, et al. Reduction of Circulating Neutrophils Precedes and Accompanies Type 1 Diabetes. Diabetes 2013;62(6):2072-2077. doi: 10.2337/db12-1345</mixed-citation><mixed-citation xml:lang="en">Valle A, Giamporcaro GM, Scavini M, Stabilini A, Grogan P, Bianconi E, et al. Reduction of Circulating Neutrophils Precedes and Accompanies Type 1 Diabetes. Diabetes 2013;62(6):2072-2077. doi: 10.2337/db12-1345</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Tong PC, Lee KF, So WY, Ng MH, Chan WB, Lo MK, et al. White Blood Cell Count Is Associated With Macro- and Microvascular Complications in Chinese Patients With Type 2 Diabetes. Diabetes Care 2004;27(1):216-222. doi: 10.2337/diacare.27.1.216</mixed-citation><mixed-citation xml:lang="en">Tong PC, Lee KF, So WY, Ng MH, Chan WB, Lo MK, et al. White Blood Cell Count Is Associated With Macro- and Microvascular Complications in Chinese Patients With Type 2 Diabetes. Diabetes Care 2004;27(1):216-222. doi: 10.2337/diacare.27.1.216</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Lo H, Lin S, Wang Y. The relationship among serum cytokines, chemokine, nitric oxide, and leptin in children with type 1 diabetes mellitus. Clinical Biochemistry 2004;37(8):666-672. doi: 10.1016/j.clinbiochem.2004.02.002</mixed-citation><mixed-citation xml:lang="en">Lo H, Lin S, Wang Y. The relationship among serum cytokines, chemokine, nitric oxide, and leptin in children with type 1 diabetes mellitus. Clinical Biochemistry 2004;37(8):666-672. doi: 10.1016/j.clinbiochem.2004.02.002</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Karima M, Kantarci A, Ohira T, Hasturk H, Jones VL, Nam B, et al. Enhanced superoxide release and elevated protein kinase C activity in neutrophils from diabetic patients: association with periodontitis. Journal of Leukocyte Biology 2005;78(4):862-870. doi: 10.1189/jlb.1004583</mixed-citation><mixed-citation xml:lang="en">Karima M, Kantarci A, Ohira T, Hasturk H, Jones VL, Nam B, et al. Enhanced superoxide release and elevated protein kinase C activity in neutrophils from diabetic patients: association with periodontitis. Journal of Leukocyte Biology 2005;78(4):862-870. doi: 10.1189/jlb.1004583</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Балаболкин МИ, Клебанова ЕА, Креминская ВМ. Патогенез ангиопатий при сахарном диабете. Сахарный диабет. 1999;(1):2-8. [Balabolkin MI, Klebanova EM, Kreminskaya VM. Patogenez angiopatiy pri sakharnom diabete. Diabetes mellitus. 1999;(1):2-8. doi: 10.14341/2072-0351-5725]</mixed-citation><mixed-citation xml:lang="en">Балаболкин МИ, Клебанова ЕА, Креминская ВМ. Патогенез ангиопатий при сахарном диабете. Сахарный диабет. 1999;(1):2-8. [Balabolkin MI, Klebanova EM, Kreminskaya VM. Patogenez angiopatiy pri sakharnom diabete. Diabetes mellitus. 1999;(1):2-8. doi: 10.14341/2072-0351-5725]</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Hayasaka S, Zhang X, Cui H, Yanagisawa S, Chi Z, Hayasaka Y, et al. Chemokines and Sho (Zheng in Chinese) of Chinese-Korean-Japanese medicine in patients with diabetic vitreoretinopathy. Am. J. Chin. Med. 2006;34(04):537-543. doi: 10.1142/S0192415X06004077</mixed-citation><mixed-citation xml:lang="en">Hayasaka S, Zhang X, Cui H, Yanagisawa S, Chi Z, Hayasaka Y, et al. Chemokines and Sho (Zheng in Chinese) of Chinese-Korean-Japanese medicine in patients with diabetic vitreoretinopathy. Am. J. Chin. Med. 2006;34(04):537-543. doi: 10.1142/S0192415X06004077</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Morii T, Fujita H, Narita T, Shimotomai T, Fujishima H, Yoshioka N, et al. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy. J. Diabetes Complications 2003;17(1):11-15. doi: 10.1016/S1056-8727(02)00176-9</mixed-citation><mixed-citation xml:lang="en">Morii T, Fujita H, Narita T, Shimotomai T, Fujishima H, Yoshioka N, et al. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy. J. Diabetes Complications 2003;17(1):11-15. doi: 10.1016/S1056-8727(02)00176-9</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Nabi AHMN, Islam LN, Rahman MM, Biswas KB. Polymorphonuclear Neutrophil Dysfunctions Streptozotocin-induced Type 1 Diabetic Rats. Journal of Biochemistry and Molecular Biology 2005;38(6):661-667. PubMed PMID: 16336780</mixed-citation><mixed-citation xml:lang="en">Nabi AHMN, Islam LN, Rahman MM, Biswas KB. Polymorphonuclear Neutrophil Dysfunctions Streptozotocin-induced Type 1 Diabetic Rats. Journal of Biochemistry and Molecular Biology 2005;38(6):661-667. PubMed PMID: 16336780</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kannan Y, Tokunaga M, Moriyama M, Kinoshita H, Nakamura Y. Diabetic neutrophil dysfunction and troglitazone. Clin Exp Immunol 2004;137(2):263-271. doi: 10.1111/j.1365-2249.2004.02532.x</mixed-citation><mixed-citation xml:lang="en">Kannan Y, Tokunaga M, Moriyama M, Kinoshita H, Nakamura Y. Diabetic neutrophil dysfunction and troglitazone. Clin Exp Immunol 2004;137(2):263-271. doi: 10.1111/j.1365-2249.2004.02532.x</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Chanchamroen S, Kewcharoenwong C, Susaengrat W, Ato M, Lertmemongkolchai G. Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects. Infect Immun 2008;77(1):456-463. doi: 10.1128/IAI.00503-08</mixed-citation><mixed-citation xml:lang="en">Chanchamroen S, Kewcharoenwong C, Susaengrat W, Ato M, Lertmemongkolchai G. Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects. Infect Immun 2008;77(1):456-463. doi: 10.1128/IAI.00503-08</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Tennenberg SD. Absence of Lipopolysaccharide-Induced Inhibition of Neutrophil Apoptosis in Patients With Diabetes. Arch Surg 1999;134(11):1229-1233. doi: 10.1001/archsurg.134.11.1229</mixed-citation><mixed-citation xml:lang="en">Tennenberg SD. Absence of Lipopolysaccharide-Induced Inhibition of Neutrophil Apoptosis in Patients With Diabetes. Arch Surg 1999;134(11):1229-1233. doi: 10.1001/archsurg.134.11.1229</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Casqueiro J, Casqueiro J, Alves C. Cresio Infections in patients with diabetes mellitus: A review of pathogenesis. Indian J Endocrinol Metab 2012;16 Suppl 1(l1):27. doi: 10.4103/2230-8210.94253</mixed-citation><mixed-citation xml:lang="en">Casqueiro J, Casqueiro J, Alves C. Cresio Infections in patients with diabetes mellitus: A review of pathogenesis. Indian J Endocrinol Metab 2012;16 Suppl 1(l1):27. doi: 10.4103/2230-8210.94253</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Walrand S, Guillet C, Boirie Y, Vasson M. In vivo evidences that insulin egulates human polymorphonuclear neutrophil functions. Journal of Leukocyte Biology 2004;76(6):1104-1110. doi: 10.1189/jlb.0104050</mixed-citation><mixed-citation xml:lang="en">Walrand S, Guillet C, Boirie Y, Vasson M. In vivo evidences that insulin egulates human polymorphonuclear neutrophil functions. Journal of Leukocyte Biology 2004;76(6):1104-1110. doi: 10.1189/jlb.0104050</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kaczmarek M, Lewandowicz-Uszyńska A, Iwanicka Z, Jankowski A. Whole blood neutrophil chemiluminescence in children with diabetes depending on their clinical condition. Centr Eur J Immunol 2012;4(4):345-349. doi: 10.5114/ceji.2012.32723</mixed-citation><mixed-citation xml:lang="en">Kaczmarek M, Lewandowicz-Uszyńska A, Iwanicka Z, Jankowski A. Whole blood neutrophil chemiluminescence in children with diabetes depending on their clinical condition. Centr Eur J Immunol 2012;4(4):345-349. doi: 10.5114/ceji.2012.32723</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Ziegler D, Sohr CG, Nourooz-Zadeh J. Oxidative stress and antioxidant defense in relation to the severity of diabetic poly-neuropathy and autonomic neuropathy. Diabetes Care 2004;27(9):2178-2183. doi: 10.2337/diacare.27.9.2178</mixed-citation><mixed-citation xml:lang="en">Ziegler D, Sohr CG, Nourooz-Zadeh J. Oxidative stress and antioxidant defense in relation to the severity of diabetic poly-neuropathy and autonomic neuropathy. Diabetes Care 2004;27(9):2178-2183. doi: 10.2337/diacare.27.9.2178</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Seo KH, Na JO, Moon SH, Uh ST, Kim YH, Park CS. Neutrophil Apoptosis and H2O2 Release by LPS in Diabetics. Tuberculosis and Respiratory Diseases. 2004; 57 (3): 250-256. Available from: http://www.e-trd.org/abstract/view_article.php?year=2008&amp;no=707&amp;page_list=abslist</mixed-citation><mixed-citation xml:lang="en">Seo KH, Na JO, Moon SH, Uh ST, Kim YH, Park CS. Neutrophil Apoptosis and H2O2 Release by LPS in Diabetics. Tuberculosis and Respiratory Diseases. 2004; 57 (3): 250-256. Available from: http://www.e-trd.org/abstract/view_article.php?year=2008&amp;no=707&amp;page_list=abslist</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang B, Hirahashi J, Cullere X, Mayadas TN. Elucidation of Molecular Events Leading to Neutrophil Apoptosis following Phagocytosis: cross-talk between caspase 8, reactive oxygen species, and mapk/erk activation. Journal of Biological Chemistry 2003;278(31):28443-28454. doi: 10.1074/jbc.M210727200</mixed-citation><mixed-citation xml:lang="en">Zhang B, Hirahashi J, Cullere X, Mayadas TN. Elucidation of Molecular Events Leading to Neutrophil Apoptosis following Phagocytosis: cross-talk between caspase 8, reactive oxygen species, and mapk/erk activation. Journal of Biological Chemistry 2003;278(31):28443-28454. doi: 10.1074/jbc.M210727200</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Glowacka E, Banasik M, Lewkowicz P, Tchorzewski H. The effect of LPS on neutrophils from patients with high risk of type 1 diabetes mellitus in relation to IL-8, IL-10 and IL-12 production and apoptosis in vitro. Scand J Immunol 2002;55(2):210-217. doi: 10.1046/j.1365-3083.2002.01046.x</mixed-citation><mixed-citation xml:lang="en">Glowacka E, Banasik M, Lewkowicz P, Tchorzewski H. The effect of LPS on neutrophils from patients with high risk of type 1 diabetes mellitus in relation to IL-8, IL-10 and IL-12 production and apoptosis in vitro. Scand J Immunol 2002;55(2):210-217. doi: 10.1046/j.1365-3083.2002.01046.x</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
